FDA Drug Application (050625) for SANDIMMUNE by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number050625
Product Number001
FormCAPSULE;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSANDIMMUNE
Active IngredientCYCLOSPORINE

Active IngredientCount
List of drugs with Active Ingredient CYCLOSPORINE5


Back to FDA Applications sponsored by NOVARTIS